SNCG and supranuclear palsy, progressive, 1: In the only study focused on CSF biomarkers in PSP and CBS, Anastassiadis and co-authors found that 35.9% of CBS and 28.6% of PSP patients were α-synuclein-positive, as detected by SAA [119].